liraglutide
Generic: liraglutide
Labeler: teva pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
liraglutide
Generic Name
liraglutide
Labeler
teva pharmaceuticals, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
liraglutide 6 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0480-7250
Product ID
0480-7250_0fc0780a-0d59-4900-9aa2-16bd4e3d3741
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214568
Listing Expiration
2027-12-31
Marketing Start
2025-08-28
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04807250
Hyphenated Format
0480-7250
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
liraglutide (source: ndc)
Generic Name
liraglutide (source: ndc)
Application Number
ANDA214568 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 6 mg/mL
Packaging
- 5 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "0fc0780a-0d59-4900-9aa2-16bd4e3d3741", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["2735350"], "spl_set_id": ["625ac780-70a9-41e4-a892-bcba0f803f1c"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0480-7250-46", "marketing_start_date": "20250828"}], "brand_name": "Liraglutide", "product_id": "0480-7250_0fc0780a-0d59-4900-9aa2-16bd4e3d3741", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0480-7250", "generic_name": "Liraglutide", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liraglutide", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "ANDA214568", "marketing_category": "ANDA", "marketing_start_date": "20250828", "listing_expiration_date": "20271231"}